HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Double primary lung cancers producing alpha-fetoprotein].

Abstract
A 81-year-old male with a high serum alpha-fetoprotein (AFP) level of 2644 ng/ml underwent left pneumonectomy for squamous cell carcinoma in the lower lobe and large cell carcinoma in the upper lobe. Both tumors were classified as pathological T2N0M0 and stage I. The AFP level was normalized to be 19 ng/ml in 49th postoperative day. Immunohistochemical staining using anti-AFP antibody demonstrated AFP granules only in the large cell carcinoma. The study of lectin affinity against the serum AFP revealed that the concanavalin A (Con-A) non-reactive fraction rate was 14%, the lentil agglutinin (LCA) non-reactive and strongly reactive subfractions were 16.7 and 83%, respectively and P2, P4 and P5 subfractions of the erythroaggultinating phytohemagglutinin (E-PHA) were 58.6, 24.9 and 16.5%, respectively. According to the analysis of 21 cases reported in the Japanese literature including our case, the AFP did not demonstrate a common affinity pattern against the Con-A but the common pattern resembling hepatocellular carcinoma against LCA and E-PHA.
AuthorsT Bessho, S Miyoshi, S Maebeya, T Suzuma, I Hirai, Y Naito
Journal[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai (Nihon Kyobu Geka Gakkai Zasshi) Vol. 44 Issue 12 Pg. 2216-20 (Dec 1996) ISSN: 0369-4739 [Print] Japan
PMID8990900 (Publication Type: Case Reports, English Abstract, Journal Article, Review)
Chemical References
  • Biomarkers, Tumor
  • Lectins
  • alpha-Fetoproteins
Topics
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (metabolism)
  • Carcinoma, Large Cell (metabolism, pathology, surgery)
  • Carcinoma, Squamous Cell (metabolism, pathology, surgery)
  • Humans
  • Lectins (metabolism)
  • Lung Neoplasms (metabolism, pathology, surgery)
  • Male
  • Neoplasms, Multiple Primary
  • Protein Binding
  • alpha-Fetoproteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: